A Japanese health ministry proposal to impose steeper price cuts on certain medicines deemed to carry poor cost-effectiveness profiles cleared…
HOME > TOP STORIES
TOP STORIES
-
REGULATORY All 4 Contenders in LDP Leadership Race Vow to Expand COVID-19 Measures
September 21, 2021
-
REGULATORY Japan to Start Discussions in October on Reinstating HPV Vaccine Recommendation
September 21, 2021
-
BUSINESS Sumitomo Dainippon Expects Twymeeg’s Initial Uptake in Combo, but Eyes 1st Line Monotherapy Use Too
September 17, 2021
-
BUSINESS White Matter Found in COVID-19 Vaccine Vials Not Contaminant: Pfizer
September 16, 2021
-
REGULATORY Tainted Moderna Jabs Run Afoul of PMD Law: Minister
September 16, 2021
-
REGULATORY Japan Eyes Legal System to Ensure Generic Supplies in New Industry Vision, Key Official Says It’s Difficult with Companies’ Own Efforts Alone
September 15, 2021
-
REGULATORY Japan Unveils New Pharma Industry Vision, 1st Update in 8 Years
September 14, 2021
-
BUSINESS Chugai Lifts Shipment Curbs for Edirol, Easing Active Vitamin D3 Shortages
September 13, 2021
-
REGULATORY Causal Link between Deaths and Recalled Batch of Moderna Jab “Indeterminable”
September 13, 2021
-
REGULATORY Japan Should Arrange Boosters Immediately, Mix-and-Match Doses Too: LDP
September 10, 2021
-
BUSINESS Follow-On AGs Gaining Ground with 10 Launches in 2 Years, More Expected amid Generic Quality Concerns
September 9, 2021
-
BUSINESS MSD Leading in Oral COVID-19 Drug Race in Japan, Trailed by Pfizer; Shionogi Top Domestic Player
September 8, 2021
-
REGULATORY Japan Strikes Deal for 150 Million Novavax Vaccine Doses, Supply Could Start Early Next Year
September 7, 2021
-
BUSINESS Takeda Faces New Problem on Leuplin, System Glitch Cripples Supply of 1, 3-Month Products
September 7, 2021
-
BUSINESS GSK Files COVID-19 Antibody Drug Sotrovimab in Japan
September 7, 2021
-
BUSINESS Japan Pharma Officials Relieved by Exit of Suga, Hardliner on Industry
September 6, 2021
-
REGULATORY Entresto Clears MHLW Panel with Strings Attached, It’s Not a 1st Choice Drug
September 6, 2021
-
BUSINESS Ono Chief, Honjo Remain Divided over Opdivo Royalty in Direct Face-Off
September 3, 2021
-
REGULATORY Nationwide On-Site Inspections Identify GMP Issues at 9 Generic Plants: MHLW
September 3, 2021
-
BUSINESS Takeda Recalling Suspended Batches of Moderna Jabs in Japan; Administrative Action Possible
September 2, 2021
ページ
A Japanese drug pricing panel on November 11 discussed ways to respond to the US most-favored-nation (MFN) policy, with healthcare…
On paper, things should be looking up for Japan’s pharmaceutical wholesalers. Industry expectations are mounting that the average gap between NHI and market prices will narrow further in FY2026 from the previous year’s record low of 4.8%.A shrinking gap should…
Japan is set to add 16 new drugs to its NHI reimbursement price list on November 13, including a subcutaneous…
Tariffs have been a defining feature of US trade policy under President Donald Trump’s second administration. Since Trump unveiled his “reciprocal” tariff policy in April 2025, the landscape has shifted repeatedly.In February 2026, the US Supreme Court invalidated tariffs imposed…
Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…